2018 US Medicinal Products
Financial Strength Rankings using Artificial Intelligence
Top rated | 12 of 48 |
Best rating | 2,152 % |
Worst rating | -2,339 % |
New companies | 5 |
Negative Economic Capital Ratio | 21 of 48 |
Financial Strength Rankings using Artificial Intelligence
Top rated | 12 of 48 |
Best rating | 2,152 % |
Worst rating | -2,339 % |
New companies | 5 |
Negative Economic Capital Ratio | 21 of 48 |
Navidea Biopharmaceuticals Inc. climbed 32 positions from 33 to 1 due it’s excellent Net Income.FITLIFE BRANDS INC. lost 24 positions from 14 to 38 due it’s bad Assets.MARIMED INC. entered the 2018 ranking at rank 15, making it the best newcomer.
Revenues | 28.2 B |
Assets | 45.6 B |
Expenses | 27.1 B |
Stockholders Equity | 18.5 B |
Unprofitable Companies | 27 of 48 |
Source: https://openai.com/dall-e-2/ RealRate’s 2023 ranking for the U.S. Consulting industry is hot [...]
Source: https://openai.com/dall-e-2/ RealRate’s 2023 ranking for the U.S. Motor industry has just [...]
Source: https://openai.com/dall-e-2/ RealRate’s 2023 ranking for the U.S. Brokerage industry is now [...]
Source: https://openai.com/dall-e-2/ RealRate’s 2023 ranking for the U.S. Semiconductor industry has just [...]
We are excited to announce that Holger Bartel, the CEO of RealRate, has [...]
Source: https://openai.com/dall-e-2/ RealRate’s 2023 ranking for the U.S. Petroleum industry has just [...]
RealRate CEO Dr. Holger Bartel will join InPeak to discuss all things AI [...]
In the complex world of finance, RealRate offers businesses clear, unbiased, and understandable [...]
This year's rating information is fee-based. Please request rates at
james.woods@realrate.ai